By Dr Sarah Larney

Books

Winsley NC; Zador D; Larney S; Dolan K, 2016, Patient motivations, perceptions and experiences of opioid substitution therapy in prison, NDARC Technical Report Number 332, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Technical%20Report%20Number%20332.pdf

Degenhardt LJ; Gibson G; Leung J; Kumvaj M; Larney S, 2016, Searching the grey literature to access research on illicit drug use, HIV and viral hepatitis A resource to identify drug-related databases and websites, Technical Report Number 334, National Drug and Alcohol Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/resource/searching-grey-literature-access-research-illicit-drug-use-hiv-and-viral-hepatitis-resource

Larney S; Toson B; Burns LA; Dolan K, 2011, Opioid substitution treatment in prison and post-release: Effects on criminal recidivism and mortality, Original, National Drug Law Enforcement Research Fund (NDLERF), Canberra, ACT, http://www.ndlerf.gov.au/pub/Monograph_37.pdf

Larney S; Dolan K, 2008, Demand reduction strategies in closed settings in China, Indonesia and Viet Nam, Original, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia

Larney S; Morton P; Dolan K, 2007, Hiv Prevention, Treatment And Care In Prisons In South-East Asia, Original, National Drug and Alcohol Research Centre, University of New, Sydney, NSW, Sydney, http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR+288-292/$file/TR290_TOC_ABSTRACT.pdf

Larney S; Matthers B; Dolan K, 2007, Illicit drug treatment in prison: Detoxification, drug-free units, therapeutic communities and opioid substitution treatment, Original, National Drug & Alcohol Research Centre, Randwick, NSW

Back to profile page